Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
BIOMARIN PHARMACEUTICAL INCListing on record | Award | — | SEC | |
Option Care Health, Inc.Listing on record | Award | — | SEC | |
SOUTHERN NATURAL RESOURCES INC INCENTIVEListing unverified | Award | — | SEC | |
SOUTHERN NATURAL RESOURCES INC INCENTIVEListing unverified | Award | — | SEC | |
BIOMARIN PHARMACEUTICAL INCListing on record | Award | — | SEC | |
Option Care Health, Inc.Listing on record | Award | — | SEC | |
BIOMARIN PHARMACEUTICAL INCListing on record | Award | — | SEC | |
SOUTHERN NATURAL RESOURCES INC INCENTIVEListing unverified | Award | — | SEC | |
Option Care Health, Inc.Listing on record | Award | — | SEC | |
Option Care Health, Inc.Listing on record | Award | — | SEC | |
BIOMARIN PHARMACEUTICAL INCListing on record | Award | — | SEC | |
Syneos Health, Inc.Listing unverified | Other | $151.4K | SEC | |
Syneos Health, Inc.Listing unverified | Other | — | SEC | |
Syneos Health, Inc.Listing unverified | Award | — | SEC | |
SOUTHERN NATURAL RESOURCES INC INCENTIVEListing unverified | AwardD (derivative) | — | SEC | |
SOUTHERN NATURAL RESOURCES INC INCENTIVEListing unverified | Award | — | SEC | |
Turning Point Therapeutics, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
SOUTHERN NATURAL RESOURCES INC INCENTIVEListing unverified | Award | — | SEC | |
SOUTHERN NATURAL RESOURCES INC INCENTIVEListing unverified | AwardD (derivative) | — | SEC | |
SOUTHERN NATURAL RESOURCES INC INCENTIVEListing unverified | Award | — | SEC | |
Syneos Health, Inc.Listing unverified | Award | — | SEC | |
Syneos Health, Inc.Listing unverified | Award | — | SEC | |
Hill-Rom Holdings, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Hill-Rom Holdings, Inc.Listing unverified | Other | — | SEC | |
Hill-Rom Holdings, Inc.Listing unverified | OtherD (derivative) | $819.3K | SEC |